France
· Delayed Price · Currency is EUR ALERS Company Description
Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and cancer.
It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, a molecular test for the surveillance of heart-transplant patients; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the evaluation of patients’ immune status against tetanus; and EBX molecular biology family, which includes a range of tests for identifying various pathogens responsible for infectious diseases and assessing the magnitude of the infection.
The company also develops other diagnostic products using molecular biology. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018.
Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.
| Country | France |
| Founded | 1997 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 300 |
| CEO | Denis Fortier |
Contact Details
Address: 7 avenue de Scandinavie Les Ulis, 91940 France | |
| Phone | 33 1 69 79 64 80 |
| Website | eurobio-scientific.com |
Stock Details
| Ticker Symbol | ALERS |
| Exchange | Euronext Paris |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | FR0013240934 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Denis Fortier | Chief Executive Officer, Member of Management Board and Chairman |
| Olivier Bosc | Manager of Finance and IT and Chief Financial Officer |
| Jean-Michel Carle Grandmougin | GM, Member of Management Board and Director |
| Cathie Marsais | Chief Operating Officer and Operations, Affairs Quality and Regulatory |
| Dejan Drljaca | CCO and Member of Management Board |
| Maarten Penning Ph.D. | Chief Technology Officer and Director of Research & Development |
| Eric Pryjda | Vice President of Sales and Marketing |
| Thomas Moreaux | CHRO and Ressources Humaines |
| Thomas Iff | Chief Business Officer |
| Hanneke Merkens | CMO, COM and Manager of International Product, Infectious and Transplant |